Solara's Puducherry and Mangalore facilities conclude USFDA audit

With zero observations

Solara Active Pharma Science announced that the USFDA has completed two successful inspections of Solara's state of the art manufacturing facilities at Puducherry and Mangalore. The inspection established that the two sites are in an Acceptable State of Compliance with Zero Form 483 inspectional observations from USFDA. The agency with their designated auditors inspected the two facilities from 17 to 21 February 2020.

Powered by Capital Market - Live News